Pulmonary Hypertension
Pulmonary Hypertension
Pulmonary Hypertension
Patient MY
28 years old
G4P2(1112) PU, 37 weeks
AOG, cephalic
CC: water vaginal discharge
PREVIOUS MEDICAL HISTORY
• Subclinical Hypothyroidism
Maintained on Levothyroxine 75mcg OD
Currently euthyroid
• Severe Pulmonary Hypertension
NYHA Class IIC
Maintained on Sildenafil 25mg OD
2D ECHO (Taken 1 month PTA)
• Concentric Left Ventricular Remodeling with Segmental Wall
Motion Abnormality but preserved LV systolic function (68%)
and normal filling pressures
• Dilated RV with Normal Systolic Pressures with signs of
Pressure and Volume overload
• Dilated RA
• MVP with Mild MR
• Mild AR, TR, PR
• High Probability for Pulmonary Hypertension, probably pre-
capillary
PHYSICAL EXAMINATION
• Awake, coherent, able to lie flat, not in respiratory distress with
pre-operative vital signs of: BP-120/60, HR – 92bpm, RR – 22,
O2 sat – 99% at 2lpm via NC
• No cyanosis, pink palpebral conjunctivae, no neck vein
distention
• Clear breath sounds, distinct heart sounds
• Strong peripheral pulses
• Airway: Mallampati 2 with adequate mouth opening and
thyromental distance and no history of obstructive sleep apnea
LABORATORY EXAMINATIONS
• CBC
Hb 11.3, Hct 37, WBC 15, PLT 320
• Bleeding Parameters
PT 92%, INR 0.98
• Creatinine – 0.8
PRE-OPERATIVE PLAN
• Maintain on NPO
• Double line
• Premeds: Pantoprazole, Metoclopramide
• Secure 1 unit pRBC
• Plan: CSEA
• Dobutamine drip
• Additional monitors: Arterial line
INTRAOPERATIVE COURSE
• Spinal anesthesia with 2.5mg bupivacaine (H) with subsequent
administration of 16mg bupivacaine (I) via epidural catheter
• Stable BP range at 110-140/70-80 mmHg maintained on
dobutamine drip at 3 to 5mkm
• No desaturations while maintained on O2 at 2lpm via NC
• Adequate urine output
• S/P Primary Cesarean Section with Bilateral Salpingectomy
POST-OPERATIVE COURSE
• Post operative medications: epidural morphine, paracetamol,
tramadol+paracetamol
• Dobutamine was weaned off
• O2 support was maintained at 2lpm via NC
• Repeat CBC: Hb 9.9, Hct 31.4
• Sildenafil resumed at postoperative day 2
TWO WEEKS LATER
• Readmission due to episodes of dyspnea
• Exacerbation of pulmonary Hypertension
• Underwent TEE under sedation
• Discharged with improved condition
ONE MONTH AFTER
• Readmission due to episodes of dyspnea again
• Managed as a case of CAP-MR
• Discharged after 9 days with improved condition
PULMONARY
HYPERTENSION
PULMONARY HYPERTENSION
• Heterogeneous disease that may be a pulmonary or a left sided
heart problem
• Mean pulmonary Artery pressure of more than or equal to 20
mmHg
PULMONARY HYPERTENSION
PATHOPHYSIOLOGY
PATHOPHYSIOLOGY
DIAGNOSIS
• Symptoms: Dyspnea, fatigue
• Signs: Venous congestion, split S2, tricuspid regurgitant
murmurs
• Labs: ECG, echocardiogram, Chest x-ray, Right heart
catheterization, pulmonary function test, sleep studies, CT
angiography
PHARMACOLOGIC MANAGEMENT
• Prostanoids: Epoprostanol,
Treprostinil, Selexipag
• Endothelin Antagonists: Bosentan,
Macitetan, Ambrisentan
• Nitric Oxide Pathway Effectors:
Sildenafil, Tadalafil, Riociguat
PERI-OPERATIVE RISKS
• Four fold increase in major peri-operative cardiovascular events
• Risk factors: Elevated RAP (>7mmHg), decreased 6-min
walking distance, use of pressors
PRE-OPERATIVE ASSESMENT
• Patient-Related Factors: Severity of PAH, RV dysfunction,
OSA, Low exercise capacity, ASA of 2 or more
• Procedure-Related Factors: emergency surgery, high and
intermediate risk surgery, need for vasopressors, prolonged
surgery of more than 3 hours
PATIENT OPTIMIZATION
• Pre-surgery visit 2 to 4 weeks prior for disease stratification
• Repeat laboratory assessment
• Assess the need for diuresis, advanced PH therapeutics,
afterload reduction, arrhythmia management, inotropes
• Pulmonary optimization
• Medications should be taken on the morning of the day of
surgery
INTRA-OPERATIVE GOALS
• Main Goal: prevent acute RV dysfunction and maintain cardiac
index to ensure adequate end –organ perfusion
• Avoid hypotension (MAP >60)
• Maintain normal sinus rhythm
• Avoid factors that mitigate increase PVR (hypoxia, hypercarbia,
acidosis, pain, hypothermia)
• Avoid high airway pressures
• Maintain baseline RV loading conditions
INTRA-OPERATIVE GOALS
• Use of Diuretics and PAH directed therapies to optimize central
venous pressures
• Use of inotropes and pulmonary vasodilating agents
ANESTHESIA MANAGEMENT
• Main goal: maintenance of hemodynamic stability
• Choice of technique depends on each case
• Consider type of surgery
GENERAL ANESTHESIA
• Induction Agents: Etomidate, propofol, opioids
• Do not use ketamine
• Muscle relaxant: Succinylcholine or Rocuronium
• Minimizing response to intubation: lidocaine, fentanyl
REGIONAL ANESTHESIA
• Avoid single shot spinal anesthesia
• Epidural is a better choice
• Standby vasopressors
OBSTETRIC ANESTHESIA
• Generally discouraged
• Endothelin antagonist – category X, prostacyclins and PDE5
inhibitors – Category B
• Invasive monitoring, Low dose vasopressors, inodilators
• Epidural anesthesia is recommended
• Cesarean Section vs Vaginal Delivery
• Critical period: post-partum
VASOPRESSORS
• Norepinephrine and vasopressin (0.08 – 0.1 units/min)
• Avoid phenylephrine and epinephrine
• Inodilators: Milrinone (0.25 to 0.75 mkm) or dobutamine (2.5 to
10 mkm)
REFERENCES
• Evaluation and Management of Pulmonary Hypertension in
Noncardiac Surgery: A Scientific Statement From the American
Heart Association
• Harrison’s Internal Medicine Chapter 283 Pulmonary
Hypertension
• Focused Review of Perioperative Care of Patients with
Pulmonary Hypertension and Proposal of a Perioperative
Pathway
THANKS!